Patrick J. Mcenany - Nov 11, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director, Chairman of Board of Directors
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
Nov 11, 2024
Transactions value $
-$9,627,422
Form type
4
Date filed
11/13/2024, 05:44 PM
Previous filing
Aug 26, 2024
Next filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $922K +230K +5.14% $4.01 4.71M Nov 11, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$5.42M -230K -4.89% $23.55 4.48M Nov 11, 2024 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $281K +70K +1.56% $4.01 4.55M Nov 12, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$1.64M -70K -1.54% $23.42 4.48M Nov 12, 2024 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Options Exercise $680K +192K +4.29% $3.54 4.67M Nov 12, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$4.45M -192K -4.11% $23.20 4.48M Nov 12, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -230K -8.87% $0.00 2.36M Nov 11, 2024 Common Stock 230K $4.01 Direct F5
transaction CPRX Options to purchase common stock Options Exercise $0 -70K -2.96% $0.00 2.29M Nov 12, 2024 Common Stock 70K $4.01 Direct F5
transaction CPRX Options to purchase common stock Options Exercise $0 -192K -8.37% $0.00 2.1M Nov 12, 2024 Common Stock 192K $3.54 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.29 to $23.873 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.30 to $23.50 per share.
F4 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.03 to $23.48 per share.
F5 Options vested in three equal tranches on January 2, 2019, 2020 and 2021.
F6 Options vested in three equal tranches on May 29, 2019, 2020 and 2021.